November 28, 2018 8:07am
If the sector runs out of buyers, it runs into trouble (just like a fire that runs out of wood).
Pre-opn indications: Yesterday’s dog is the today’s hero!
As the leading voice of investors; I am not always a doom and gloom reporter but a man who has been “there” with the gray hair and a readership following with real numbers to prove it!
A trusted source of factual reporting of preludes and aftermaths!
I post about “indication intelligence” devoting my time to collection and analysis of information to assist investors in the perception of sector vulnerabilities and strengths – it’s more than opinion, the facts and truth need to be recognized!
U.S. stock index futures are climbing
Dow futures are UP +0.66% (+163 points) and NASDAQ futures are UP +0.63% (+43 points)
U.S. stock index futures posted solid gains ahead of Wednesday's open as investors awaited a key speech from the Fed;
European stocks were slightly higher, as investors attempted to decipher conflicting signals over the potential for a reprieve in the U.S.-Sino trade dispute.
Asian equities saw gains as investors wait for an important meeting between U.S. President Donald Trump and Chinese leader Xi Jinping later this week.
Data docket: the gross domestic product (GDP) figures are due out at 8:30 a.m. ET.
- The iShares Nasdaq Biotechnology (IBB) is indicating a POSITIVE +0.66% UPSIDE
- The SPDR S&P Biotech ETF (XBI) is NOT indicating
- The Health Care Select Sector SPDR ETF (XLV) is indicating a POSITIVE +0.16% UPSIDE
- The iShares Russell 2000 (IWM) is indicating a POSITIVE +0.5% UPSIDE
Today’s biggest interest, “Fed Chair Jerome Powell is expected to speak at the Economic Club of New York. During the event, Powell is slated to talk about the Fed's framework for monitoring financial stability. Investors are eagerly awaiting the speech as stocks have fallen in part because of fears the central bank may be tightening monetary policy too quickly <CNBC>.”
Some think that selling swings are not over; while and many believe they should sell into rallies!
I am in both camps depending on where the entry purchase price stands believing that RISK is an infectious disease.
Last night’s closing bell remarks, “feeling the pain of a low volume retreat after a three session gain and a holiday.”
Last night’s percentage (%) indicators:
- Review the range of the 7 upside from +0.42% (AXGN) to +6.03% (OSIR) while the 37 downside ranged from -0.44% (CRSP) to -11.98% (STML) with a 1 flat close (ONVO).
- 1 out of the 7 upside had higher (than the 3 month average) volume
- 10 out of the 37 downside experienced greater volume (than the 3 month average).
In 19 sessions in November – there were 1 holiday, 8 positive closes, 1 neutral and 9 negative closes
- In 23 sessions in October – there were 17 negative closes and 6 positive sessions;
- In 19 sessions in September – there were 10 negative closes and 9 positive sessions;
- In 21 August sessions – 6 had negative and 15 had positive closes
Companies in my headlights – It’s your decision; I provide an idea and context:
Those sector equities that got “whacked’ on the knuckles, will today get a pat on the head!
… IF macro events don’t go astray
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.